Advertisement

Molecular Medicine

, Volume 13, Issue 9–10, pp 488–494 | Cite as

Adrenomedullin and Adrenomedullin Binding Protein-1 Protect Endothelium-Dependent Vascular Relaxation in Sepsis

  • Mian Zhou
  • Subir R. Maitra
  • Ping Wang
Research Article

Abstract

Downregulation of vascular endothelial constitutive nitric oxide synthase (ecNOS) contributes to the vascular hyporesponsiveness in sepsis. Although coadministration of the potent vasodilatory peptide adrenomedulin (AM) and the newly discovered AM binding protein (AMBP-1) maintains cardiovascular stability and reduces mortality in sepsis, it remains unknown whether AM/AMBP-1 prevents endothelial cell dysfunction. To investigate this possibility, we subjected adult male rats to sepsis by cecal ligation and puncture (CLP), with or without subsequent intravenous administration of the combination of AM (12 µg/kg) and AMBP-1 (40 µg/kg). Thoracic aortae were harvested 20 h after CLP (i.e., the late stage of sepsis) and endothelium-dependent vascular relaxation was determined by the addition of acetylcholine (ACh) in an organ bath system. In addition, ecNOS gene and protein expression was assessed by RT-PCR and immunohistochemistry, respectively. The results indicate that ACh-induced (i.e., endothelium-dependent) vascular relaxation was significantly reduced 20 h after CLP. Administration of AM/AMBP-1 prevented the reduction of vascular relaxation. In addition, ecNOS gene expression in aortic and pulmonary tissues was downregulated 20 h after CLP and AM/AMBP-1 attenuated such a reduction. Moreover, the decreased ecNOS staining in thoracic aortae of septic animals was prevented by the treatment with AM/AMBP-1. These results, taken together, indicate that AM/AMBP-1 preserves ecNOS and prevents reduced endothelium-dependent vascular relaxation (i.e., endothelial cell dysfunction) in sepsis. In light of our recent finding that AM/AMBP-1 improves organ function and reduces mortality in sepsis, it is most likely that the protective effect of these compounds on ecNOS is a mechanism responsible for the salutary effect of AM/AMBP-1 in sepsis.

Notes

Acknowledgments

This investigation was supported by National Institutes of Health (NIH) grants R01 GM057468 and R01 HL076179 (P Wang). The authors sincerely thank Zheng F Ba, Dale E Fowler, Shaolong Yang, and David A Ornan for their excellent assistance.

References

  1. 1.
    Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344:699–709.CrossRefGoogle Scholar
  2. 2.
    Martin GS, Mannino DM, Eaton S, Moss M. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348: 1546–54.CrossRefGoogle Scholar
  3. 3.
    Hotchkiss RS, Karl IE. (2003) The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138–50.CrossRefGoogle Scholar
  4. 4.
    Tracey KJ. (2002) The inflammatory reflex. Nature 420:853–9.CrossRefGoogle Scholar
  5. 5.
    Riedemann NC, Guo RF, Ward PA. (2003) Novel strategies for the treatment of sepsis. Nat. Med. 9: 517–24.CrossRefGoogle Scholar
  6. 6.
    Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:1303–10.CrossRefGoogle Scholar
  7. 7.
    Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192:553–60.CrossRefGoogle Scholar
  8. 8.
    Sakata J, Shimokubo T, Kitamura K, Nakamura S, Kangawa K, Matsuo H, Eto T. (1993) Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem. Biophys. Res. Commun. 195:921–7.CrossRefGoogle Scholar
  9. 9.
    Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, Marumo F. (1996) Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J. Clin. Endocrinol. Metab. 81: 1449–53.PubMedGoogle Scholar
  10. 10.
    Nishio K, Akai Y, Murao Y, Doi N, Ueda S, Tabuse H, Miyamoto S, Dohi K, Minamino N, Shoji H, Kitamura K, Kangawa K, Matsuo H. (1997) Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock. Crit. Care Med. 25:953–7.CrossRefGoogle Scholar
  11. 11.
    Ehlenz K, Koch B, Preuss P, Simon B, Koop I, Lang RE. (1997) High levels of circulating adrenomedullin in severe illness: correlation with C-reactive protein and evidence against the adrenal medulla as site of origin. Exp. Clin. Endocrinol. Diabetes 105:156–62.CrossRefGoogle Scholar
  12. 12.
    Ueda S, Nishio K, Minamino N, Kubo A, Akai Y, Kangawa K, Matsuo H, Fujimura Y, Yoshioka A, Masui K, Doi N, Murao Y, Miyamoto S. (1999) Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Am. J. Respir. Crit. Care Med. 160:132–6.CrossRefGoogle Scholar
  13. 13.
    Fujioka S. (2001) Increased plasma concentration of adrenomedullin during and after major surgery. Surg. Today 31:575–9.CrossRefGoogle Scholar
  14. 14.
    Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, Matsio H. (1995) Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 207:25–32.CrossRefGoogle Scholar
  15. 15.
    Shoji H, Minamina N, Kangawa K, Matsuo H. (1995) Endotoxin markedly elevates plasma concentration and gene transcription of adrenomedullin in rat. Biochem. Biophys. Res. Commun. 215:531–7.CrossRefGoogle Scholar
  16. 16.
    Ono Y, Kojima M, Okada K, Kangawa K. (1998) cDNA cloning of canine adrenomedullin and its gene expression in the heart and blood vessels in endotoxin shock. Shock 10:243–7.CrossRefGoogle Scholar
  17. 17.
    Zaks-Zilberman M, Salkowski CA, Elsasser T, Cuttitta F, Vogel SN. (1998) Induction of adrenomedullin mRNA and protein by lipopolysaccharide and paclitaxel (taxol) in murine macrophages. Infect. Immun. 66:4669–75.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Elsasser TH, Sartin JL, Martinez A, Kahl S, Montuenga L, Pio R, Fayer R, Miller MJ, Cuttitta F. (1999) Underlying disease stress augments plasma and tissue adrenomedullin (AM) responses to endotoxin: colocalized increases in AM and inducible nitric oxide synthase within pancreatic islets. Endocrinol. 140:5402–11.CrossRefGoogle Scholar
  19. 19.
    Matsui E, Kitamura K, Yoshida M, Kato J, Asada Y, Sumiyoshi A, Eto T. (2001) Biosynthesis and secretion of adrenomedullin and proadrenomedullin N-terminal 20 peptide in a rat model of endotoxin shock. Hypertens. Res. 24:543–9.CrossRefGoogle Scholar
  20. 20.
    Shindo T, Kurihara H, Kurihara Y, Morita H, Yazaki Y. (1998) Upregulation of endothelin-1 and adrenomedullin gene expression in the mouse endotoxin shock model. J. Cardiovasc. Pharmacol. 31 (Suppl 1):S541–4.CrossRefGoogle Scholar
  21. 21.
    Zhou M, Chaudry IH, Wang P. (2001) The small intestine is an important source of adrenomedullin release during polymicrobial sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281:R654–60.CrossRefGoogle Scholar
  22. 22.
    Elsasser TH, Kahl S, Martinez A, Montuenga LM, Pio R, Cuttitta F. (1999) Adrenomedullin binding protein in the plasma of multiple species: characterization by radioligand blotting. Endocrinol. 140:4908–11.CrossRefGoogle Scholar
  23. 23.
    Pio R, Martinez A, Unsworth EJ, Kowalak JA, Bengoechea JA, Zipfel PF, Elsasser TH, Cuttitta F. (2001) Complement factor H is a serum binding protein for adrenomedullin. The resulting complex modulates the bioactivities of both partners. J. Biol. Chem. 276:12292–300.CrossRefGoogle Scholar
  24. 24.
    Friese MA, Hellwage J, Jokiranta TS, Meri S, Peter HH, Eibel H, Zipfel PF. (1999) FHL-1/reconectin and factor H: two human complement regulators which are encoded by the same gene are differently expressed and regulated. Mol. Immunol. 36:809–18.CrossRefGoogle Scholar
  25. 25.
    Schwaeble W, Zwirner J, Schulz TF, Linke RP, Dierich MP, Weiss EH. (1987) Human complement factor H: expression of an additional truncated gene product of 43 kDa in human liver. Eur. J. Immunol. 17:1485–9.CrossRefGoogle Scholar
  26. 26.
    Luo W, Vik DP. (1999) Regulation of complement factor H in a human liver cell line by interferon-gamma. Scand. J. Immunol. 49:487–94.CrossRefGoogle Scholar
  27. 27.
    Schwaeble W, Schwaiger H, Brooimans RA, Barbieri A, Most J, Hirsch-Kauffmann M, Tiefenthaler M, Lappin DF, Daha MR, Whaley K. (1991) Human complement factor H. Tissue specificity in the expression of three different mRNA species. Eur. J. Biochem. 198:399–404.CrossRefGoogle Scholar
  28. 28.
    Zhou M, Ba ZF, Chaudry IH, Wang P. (2002) Adrenomedullin binding protein-1 modulates vascular responsiveness to adrenomedullin in late sepsis. Am. J. Physiol Regul. Integr. Comp. Physiol. 283:R553–60.CrossRefGoogle Scholar
  29. 29.
    Yang S, Zhou M, Fowler DE, Wang P. (2002) Mechanisms of the beneficial effect of adrenomedullin and adrenomedullin-binding protein-1 in sepsis: Down-regulation of proinflammatory cytokines. Crit. Care Med. 30:2729–35.CrossRefGoogle Scholar
  30. 30.
    Yang S, Zhou M, Chaudry IH, Wang P. (2002) Novel approach to prevent the transition from the hyperdynamic phase to the hypodynamic phase of sepsis: role of adrenomedullin and adrenomedullin binding protein-1. Ann. Surg. 236:625–33.CrossRefGoogle Scholar
  31. 31.
    Zhou M, Simms HH, Wang P. (2004) Adrenomedullin and adrenomedullin binding protein-1 attenuate vascular endothelial cell apoptosis in sepsis. Ann. Surg. 240:321–30.CrossRefGoogle Scholar
  32. 32.
    Wang W, Mitra A, Poole B, Falk S, Lucia MS, Tayal S, Schrier R. (2004) Endothelial nitric oxide synthase-deficient mice exhibit increased susceptibility to endotoxin-induced acute renal failure. Am. J. Physiol. Renal Physiol. 287:F1044–8.CrossRefGoogle Scholar
  33. 33.
    Zhou M, Wang P, Chaudry IH. (1997) Endothelial nitric oxide synthase is downregulated during hyperdynamic sepsis. Biochim. Biophys. Acta. 1335:182–90.CrossRefGoogle Scholar
  34. 34.
    Wang P, Ba ZF, Chaudry IH. (1994) Nitric oxide: to block or enhance its production during sepsis? Arch. Surg. 129:1137–43.CrossRefGoogle Scholar
  35. 35.
    Wang P, Chaudry IH. (1998) A single hit model of polymicrobial sepsis: cecal ligation and puncture. Sepsis 2:227–33.CrossRefGoogle Scholar
  36. 36.
    Yang S, Cioffi WG, Bland KI, Chaudry IH, Wang P. (1999) Differential alterations in systemic and regional oxygen delivery and consumption during the early and late stages of sepsis. J. Trauma 47:706–12.CrossRefGoogle Scholar
  37. 37.
    Wang P, Zhou M, Ba Z., Cioffi WG, Chaudry IH (1998) Upregulation of a novel potent vasodilatory peptide adrenomedullin during polymicrobial sepsis. Shock 10:118–23.CrossRefGoogle Scholar
  38. 38.
    Wang P, Yoo P, Zhou M, Cioffi, WG, Ba ZF, Chaudry IH. (1999) Reduction in vascular responsiveness to adrenomedullin during sepsis. J. Surg. Res. 85:59–66.CrossRefGoogle Scholar
  39. 39.
    Koo DJ, Zhou M, Chaudry IH, Wang P. (2001) The role of adrenomedullin in producing differential hemodynamic responses during sepsis. J. Surg. Res. 95:207–18.CrossRefGoogle Scholar
  40. 40.
    Koo DJ, Yoo P, Cioffi WG, Bland KI, Chaudry IH, Wang P. (2000) Mechanism of beneficial effects of pentoxifylline during sepsis: maintenance of adrenomedullin responsiveness and downregulation of proinflammatory cytokines. J. Surg. Res. 91:70–5.CrossRefGoogle Scholar
  41. 41.
    Kaomi H, Kanazawa H, Hirata K, Kurihara N, Yano Y, Otano S. (1995) Adrenomedullin inhibits the secretion of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, from rat alveolar macrophages. Biochem. Biophys. Res. Commun. 211:1031–5.CrossRefGoogle Scholar
  42. 42.
    Isumi Y, Kubo A, Katafuchi T, Kangawa K, Minamir N. (1999) Adrenomedullin suppresses interleukin-1_-induced tumor necrosis factor-α production in Swiss 3T3 cells. FEBS Lett. 463: 110–6.CrossRefGoogle Scholar
  43. 43.
    Koo DJ, Chaudry IH, Wang P. (1999) Kupffer cells are responsible for producing inflammatory cytokines and hepatocellular dysfunction during early sepsis. J. Surg. Res. 83:151–7.CrossRefGoogle Scholar
  44. 44.
    Wu R, Zhou M, Wang P. (2003) Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-alpha in macrophage cell line and rat Kupffer cells. Regulatory Pept. 112:19–26.CrossRefGoogle Scholar
  45. 45.
    Wang P, Ba ZF, Chaudry IH. (1995) Endothelium dependent relaxation is depressed at the macro- and microcirculatory levels during sepsis. Am. J. Physiol. 269:R988–93.PubMedGoogle Scholar
  46. 46.
    Equchi S, Hirata Y, Iwanski H, Sato K, Watanabe TX, Inui P, Nakajima K, Sakakibara S, Marumo F. (1994) Structure activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells. Endocrinology 135:2454–8.CrossRefGoogle Scholar
  47. 47.
    Montuenga LM, Martinez A, Miller MA, Unsworth EJ, Cuttitta F. (1997) Expression of adrenomedullin and its receptor during embryogenesis suggests autocrine or paracrine modes of action. Endocrinology 138:440–51.CrossRefGoogle Scholar
  48. 48.
    Shimekake Y, Nagata K, Ohta S, Kambayashi Y, Teraoka H, Kitamuoa K, Eto P, Kangawa K, Matsuo H. (1995) Adrenomedullin stimulated two signal transduction pathways, cAMP accumulation and Ca2+ mobilization in bovine aortic endothelial cells. J. Biol. Chem. 270:P4412–7.CrossRefGoogle Scholar
  49. 49.
    Hinson JP, Kapas S, Smith DM. (2000) Adrenomedullin, a multifunctional regulatory peptide. Endocr. Rev. 21:138–67.PubMedGoogle Scholar
  50. 50.
    Nishimatsu H, Suzuki E, Nagata D, Mooiyama N, Satonaka H, Walsh K, Sata M, Kangawa K, Matsuo H, Gotto A, Kitamura T, Hirata Y. (2001) Adrenomedullin induces endothelium dependent vasorelaxation via the phosphatidylinositol 3-Kinase/Akt-dependent pathway in rat aorta. Circ. Res. 89:63–70.CrossRefGoogle Scholar
  51. 51.
    Cui X, Wu R, Zhou M, Dong W, Ulloa L, Yang H, Wang H, Tracey KJ, Simms HH, Wang P. (2005) Adrenomedullin and its binding protein attenuate the proinflammatory response after hemorrhage. Crit. Care Med. 33:391–8.CrossRefGoogle Scholar
  52. 52.
    Cui Y, Ji Y, Wu R, Zhou M, Wang P. (2006) Adrenomedullin binding protein-1 is downregulated during polymicrobial sepsis in the rat. Int. J. Mol. Med. 17:925–9.PubMedPubMedCentralGoogle Scholar
  53. 53.
    Vallet B. (2003) Bench-to-bedside review: Endothelial cell dysfunction in sepsis: a role in organ dysfunction? Crit. Care 7:130–8.CrossRefGoogle Scholar
  54. 54.
    Yamashita T, Kawashina S, Ohashi Y. (2000) Resistance to endotoxin shock in transgenic mice overexpressing nitric oxide synthase. Circulation 101:931–7.CrossRefGoogle Scholar
  55. 55.
    Parker JL, Adams HR. (1993) Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia. Circ. Res. 72:539–51.CrossRefGoogle Scholar

Copyright information

© Feinstein Institute for Medical Research 2007

Authors and Affiliations

  1. 1.Department of Surgery, Laboratory of Surgical ResearchNorth Shore University Hospital and Long Island Jewish Medical Center, The Feinstein Institute for Medical ResearchManhassetUSA

Personalised recommendations